... 缬沙坦相关物质A Valsartan Related Compound A 缬沙坦-心衰试验 Heart Failure Trial 缬沙坦急性心肌梗死试验 VALIANT ...
基于4个网页-相关网页
Valsartan Heart Failure Trial 心力衰竭试验
Cardiac Resynchronization heart failure Trial 衰竭的心脏再同步治疗 ; 心脏再同步治疗
Vasodilator Heart Failure Trial 血管扩张心力衰竭试验
African-American Heart Failure Trial 非洲裔美国人心衰实验
An initial trial of Revascor last year in 60 American patients with congestive heart failure saw a 75 per cent reduction in the risk of related deaths over the following 21 months.
Revascor的首次尝试,是在去年60例患有充血性心力衰竭的美国病人,在接下来的21个月里,检查证明相关的死亡风险下降了75%。
Design, Setting, and patients Multicenter, randomized controlled trial among 2331 medically stable outpatients with heart failure with left ventricular ejection fraction of 35% or less.
试验设计、设定与病人多中心随机对照试验,2331名医学上稳定的门诊心衰患者,左心室射血分数小于等于35%。
Current research interests include clinical trial design, and the pathophysiology and treatment of heart failure in companion animals.
现在研究的项目包括临床试验设计和伴侣动物心衰的病理生理学和治疗。
应用推荐